NCT04398719View on ClinicalTrials.gov

CBD-Microglia PET Study

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
CBDHealthy
Interventions
RADIATION

[11C]PBR28

The radiotracer, \[11C\]PBR28, will be administered at the beginning of each PET scan

DRUG

Low-dose lipopolysaccharide

Subjects will receive intravenous lipopolysaccharide.

DRUG

Intradermal Capsaicin

A small dose of capsaicin will be administered by intradermal injection.

Trial Locations (1)

06519

RECRUITING

Connecticut Mental Health Center, New Haven

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Yale University

OTHER